Standard treatments for CRC include surgery, chemotherapy, radiotherapy, and targeted therapy, such as epidermal growth factor receptor (EGFR) inhibitors (e.g., cetuximab) and vascular endothelial growth factor receptor (VEGFR) inhibitors (e.g., bevacizumab) (2, 3). Here, EGFR is linked to colorectal carcinoma.